152 related articles for article (PubMed ID: 37795959)
21. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
[No Abstract] [Full Text] [Related]
22. Aberrant methylation of the cyclin D2 promoter in primary small cell, nonsmall cell lung and breast cancers.
Virmani A; Rathi A; Heda S; Sugio K; Lewis C; Tonk V; Takahashi T; Roth JA; Minna JD; Euhus DM; Gazdar AF
Int J Cancer; 2003 Nov; 107(3):341-5. PubMed ID: 14506731
[TBL] [Abstract][Full Text] [Related]
23. Regulation of DNA polymerase POLD4 influences genomic instability in lung cancer.
Huang QM; Tomida S; Masuda Y; Arima C; Cao K; Kasahara TA; Osada H; Yatabe Y; Akashi T; Kamiya K; Takahashi T; Suzuki M
Cancer Res; 2010 Nov; 70(21):8407-16. PubMed ID: 20861182
[TBL] [Abstract][Full Text] [Related]
24. Effects of MALAT1 on proliferation and apo- ptosis of human non-small cell lung cancer A549 cells in vitro and tumor xenograft growth in vivo by modulating autophagy.
Ma J; Wu K; Liu K; Miao R
Cancer Biomark; 2018; 22(1):63-72. PubMed ID: 29439314
[TBL] [Abstract][Full Text] [Related]
25. Association and interaction of NFKB1 rs28362491 insertion/deletion ATTG polymorphism and PPP1R13L and CD3EAP related to lung cancer risk in a Chinese population.
Yin J; Wang H; Vogel U; Wang C; Hou W; Ma Y
Tumour Biol; 2016 Apr; 37(4):5467-73. PubMed ID: 26563375
[TBL] [Abstract][Full Text] [Related]
26. RNA polymerase II subunit D is essential for zebrafish development.
Maeta M; Kataoka M; Nishiya Y; Ogino K; Kashima M; Hirata H
Sci Rep; 2020 Aug; 10(1):13213. PubMed ID: 32764610
[TBL] [Abstract][Full Text] [Related]
27. An integrated epigenomic-transcriptomic landscape of lung cancer reveals novel methylation driver genes of diagnostic and therapeutic relevance.
Sun X; Yi J; Yang J; Han Y; Qian X; Liu Y; Li J; Lu B; Zhang J; Pan X; Liu Y; Liang M; Chen E; Liu P; Lu Y
Theranostics; 2021; 11(11):5346-5364. PubMed ID: 33859751
[No Abstract] [Full Text] [Related]
28. Knockdown of long noncoding RNA urothelial carcinoma associated 1 inhibits colorectal cancer cell proliferation and promotes apoptosis via modulating autophagy.
Song F; Li L; Liang D; Zhuo Y; Wang X; Dai H
J Cell Physiol; 2019 May; 234(5):7420-7434. PubMed ID: 30362538
[TBL] [Abstract][Full Text] [Related]
29. COMMD9 promotes TFDP1/E2F1 transcriptional activity via interaction with TFDP1 in non-small cell lung cancer.
Zhan W; Wang W; Han T; Xie C; Zhang T; Gan M; Wang JB
Cell Signal; 2017 Jan; 30():59-66. PubMed ID: 27871936
[TBL] [Abstract][Full Text] [Related]
30. GPR78 Regulates Autophagy and Drug Resistance in Non-small Cell Lung Cancer.
Liao X; Cai R; Li G; Chen F
Altern Ther Health Med; 2023 Jan; 29(1):130-136. PubMed ID: 35986740
[TBL] [Abstract][Full Text] [Related]
31. Long noncoding RNA TUG1 is downregulated in non-small cell lung cancer and can regulate CELF1 on binding to PRC2.
Lin PC; Huang HD; Chang CC; Chang YS; Yen JC; Lee CC; Chang WH; Liu TC; Chang JG
BMC Cancer; 2016 Aug; 16():583. PubMed ID: 27485439
[TBL] [Abstract][Full Text] [Related]
32. High Expression of Rab-like 3 (Rabl3) is Associated with Poor Survival of Patients with Non-Small Cell Lung Cancer via Repression of MAPK8/9/10-Mediated Autophagy.
Zhang W; Sun J; Luo J
Med Sci Monit; 2016 May; 22():1582-8. PubMed ID: 27164297
[TBL] [Abstract][Full Text] [Related]
33. Frequent silencing of the candidate tumor suppressor PCDH20 by epigenetic mechanism in non-small-cell lung cancers.
Imoto I; Izumi H; Yokoi S; Hosoda H; Shibata T; Hosoda F; Ohki M; Hirohashi S; Inazawa J
Cancer Res; 2006 May; 66(9):4617-26. PubMed ID: 16651412
[TBL] [Abstract][Full Text] [Related]
34. 1A6/DRIM, a novel t-UTP, activates RNA polymerase I transcription and promotes cell proliferation.
Peng Q; Wu J; Zhang Y; Liu Y; Kong R; Hu L; Du X; Ke Y
PLoS One; 2010 Dec; 5(12):e14244. PubMed ID: 21151873
[TBL] [Abstract][Full Text] [Related]
35. EZH2-mediated Puma gene repression regulates non-small cell lung cancer cell proliferation and cisplatin-induced apoptosis.
Liu H; Li W; Yu X; Gao F; Duan Z; Ma X; Tan S; Yuan Y; Liu L; Wang J; Zhou X; Yang Y
Oncotarget; 2016 Aug; 7(35):56338-56354. PubMed ID: 27472460
[TBL] [Abstract][Full Text] [Related]
36. Re-expression of ARHI (DIRAS3) induces autophagy in breast cancer cells and enhances the inhibitory effect of paclitaxel.
Zou CF; Jia L; Jin H; Yao M; Zhao N; Huan J; Lu Z; Bast RC; Feng Y; Yu Y
BMC Cancer; 2011 Jan; 11():22. PubMed ID: 21244707
[TBL] [Abstract][Full Text] [Related]
37. Circular RNA circ_0003028 contributes to tumorigenesis by regulating GOT2 via miR-1298-5p in non-small cell lung cancer.
Guan H; Sun C; Gu Y; Li J; Ji J; Zhu Y
Bioengineered; 2021 Dec; 12(1):2326-2340. PubMed ID: 34077306
[TBL] [Abstract][Full Text] [Related]
38. Epigenetic mechanisms for silencing glutathione S-transferase m2 expression by hypermethylated specificity protein 1 binding in lung cancer.
Tang SC; Wu MF; Wong RH; Liu YF; Tang LC; Lai CH; Hsu CP; Ko JL
Cancer; 2011 Jul; 117(14):3209-21. PubMed ID: 21246532
[TBL] [Abstract][Full Text] [Related]
39. Knockdown of eIF3d inhibits cell proliferation through G2/M phase arrest in non-small cell lung cancer.
Lin Z; Xiong L; Lin Q
Med Oncol; 2015 Jul; 32(7):183. PubMed ID: 26008152
[TBL] [Abstract][Full Text] [Related]
40. Integrative CAGE and DNA Methylation Profiling Identify Epigenetically Regulated Genes in NSCLC.
Horie M; Kaczkowski B; Ohshima M; Matsuzaki H; Noguchi S; Mikami Y; Lizio M; Itoh M; Kawaji H; Lassmann T; Carninci P; Hayashizaki Y; Forrest ARR; Takai D; Yamaguchi Y; Micke P; Saito A; Nagase T
Mol Cancer Res; 2017 Oct; 15(10):1354-1365. PubMed ID: 28698358
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]